Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with
efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.
The Federal Joint Committee (G - BA) specified two appropriate comparator therapies according to the approval status: Treatment - naive patients, i.e. patients who had not been treated for HIV before, were to receive
efavirenz in combination with tenofovir and emtricitabine or in combination with abacavir and lamivudine.
Not exact matches
Her research on immune reconstitution inflammatory syndrome and rifampicin -
efavirenz drug interactions has been influential
in defining treatment strategies for these common complications of integrating TB - HIV treatment.